Average Co-Inventor Count = 7.00
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (16 from 725 patents)
16 patents:
1. 12295995 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
2. 12295994 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
3. 12295996 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
4. 12214025 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
5. 11116826 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
6. 11007257 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
7. 11007258 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
8. 10898561 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
9. 10792350 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
10. 10729755 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
11. 10668138 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
12. 10576135 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
13. 10561718 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
14. 10449239 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
15. 10357551 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers